91 related articles for article (PubMed ID: 11836549)
21. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
22. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
23. Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix.
Toki T; Zhai YL; Park JS; Fujii S
Int J Gynecol Pathol; 1999 Jul; 18(3):215-9. PubMed ID: 12090589
[TBL] [Abstract][Full Text] [Related]
24. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
[TBL] [Abstract][Full Text] [Related]
25. Higher incidence of p53 mutation in cervical carcinomas with intermediate-risk HPV infection.
Kim HJ; Song ES; Hwang TS
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):213-8. PubMed ID: 11574134
[TBL] [Abstract][Full Text] [Related]
26. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
27. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions.
Humbey O; Aubin F; Cairey-Remonnay S; Riethmuller D; Pretet JL; Fest T; Seilles E; Mougin C
Eur J Obstet Gynecol Reprod Biol; 2002 Jun; 103(1):60-4. PubMed ID: 12039466
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and the long-term risk of cervical neoplasia.
van der Graaf Y; Molijn A; Doornewaard H; Quint W; van Doorn LJ; van den Tweel J
Am J Epidemiol; 2002 Jul; 156(2):158-64. PubMed ID: 12117707
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
[TBL] [Abstract][Full Text] [Related]
30. Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Mar; 96(3):736-40. PubMed ID: 15721419
[TBL] [Abstract][Full Text] [Related]
31. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
32. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
33. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
34. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer.
Wong YF; Chung TK; Cheung TH; Nobori T; Hampton GM; Wang VW; Li YF; Chang AM
Gynecol Obstet Invest; 2000; 50(1):60-3. PubMed ID: 10895031
[TBL] [Abstract][Full Text] [Related]
35. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
36. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
37. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
38. Low frequency of p53 mutations in cervical carcinomas among Brazilian women.
Pinheiro NA; Villa LL
Braz J Med Biol Res; 2001 Jun; 34(6):727-33. PubMed ID: 11378660
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
